| 000 | 01568 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514022511.0 | ||
| 264 | 0 | _c20020305 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0148-7299 | ||
| 024 | 7 |
_a10.1002/ajmg.1610 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaat-Kievit, A | |
| 245 | 0 | 0 |
_aUsing a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease. _h[electronic resource] |
| 260 |
_bAmerican journal of medical genetics _cDec 2001 |
||
| 300 |
_a737-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aDNA _xgenetics |
| 650 | 0 | 4 | _aFamily Health |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHuntingtin Protein |
| 650 | 0 | 4 |
_aHuntington Disease _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 | _aPedigree |
| 650 | 0 | 4 | _aPenetrance |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aTrinucleotide Repeats _xgenetics |
| 700 | 1 | _aHelderman-van den Enden, P | |
| 700 | 1 | _aLosekoot, M | |
| 700 | 1 | _ade Knijff, P | |
| 700 | 1 | _aBelfroid, R | |
| 700 | 1 | _aVegter-van der Vlis, M | |
| 700 | 1 | _aRoos, R | |
| 700 | 1 | _aBreuning, M | |
| 773 | 0 |
_tAmerican journal of medical genetics _gvol. 105 _gno. 8 _gp. 737-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajmg.1610 _zAvailable from publisher's website |
| 999 |
_c11714301 _d11714301 |
||